Global Bioimplants Market Size, Share, Forecast Report, 2020-2027
The Global Bioimplants Market is valued at USD 98,350 Million in 2017 and expected to register 8.6% CAGR during the forecast period (2018–2023).
Bioimplants are bioengineered products used to restore physiological functions of damaged biostructure by restoring it. The procedure is done by replacing, supporting, or enhancing the missing, damaged, or existing biological structure. The rising cases of bone degeneration cases in geriatric population, increasing demand for minimally invasive surgeries, increasing prevalence of lifestyle diseases such as obesity, diabetes, and infections and technological advancement in healthcare sector are expected to drive the growth of the market. Also, the rising research and development activities and aggressive strategies implemented by major players in the market are propelling the growth of market. For instance, in March 2018, Dentsply Sirona announced collaboration with North American Dental Group(NADG) and with this collaboration NADG has approved Dentsply Sirona as a preferred manufacturing partner.
The rising cost of bioimplant surgeries, high price of bioimplants, unfavorable reimbursement policies and lack of skilled personnel for the effective use of bioimplant products may hamper the growth of the market during the assessment period.
Segmentation:
The Global Bioimplants Market has been segmented on the basis of type, material, origin and end-user.On the basis of type, the market has been classified as cardiovascular implant, dental implants, spinal bio-implants, orthopedic implants, ophthalmic implants and others. The cardiovascular implant segment has been further divided into stents, pacing devices and others. Dental implants are classified into plate form dental implant and root form dental implants. The spinal bioimplants segment has been further divided into form dental implant, intervertebral spacers, cervical implants, and motion preservation implants. Orthopedic Implants are divided into orthobiologics, trauma implants, joint replacement implants, and knee replacement implants. The ophthalmic implants segmented has been classified into glaucoma implants, and intraocular implants.
The material segment is divided into biomaterial metals, ceramics, alloys, and others. The biomaterial metals segment has been divided into titanium, gold, silver and platinum. Based on origin, the market has been segmented into autograft, allograft, xenograft, and synthetic.The market, by end-user, has been segmented into hospitals, clinics, specialty centers, and others.
Key Players:
Some of the key players in the global bioimplants market are Abbott, Boston Scientific Corporation, Dentsply Sirona, Johnson & Johnson Services, Inc., Invibio Ltd., Integra LifeSciences, Medtronic, Smith & Nephew plc, Stryker, Wright Medical Group N.V., Zimmer Biomet, Cook Group, and C.R.Bard, Inc.
Global Bioimplants Market, by Type:
Global Bioimplants Market, by Material:
Global Bioimplants Market, by Origin:
Global Bioimplants Market, by Material:
Global Bioimplants Market, by Region:
The Middle East & Africa
Middle East
Africa
Company Profiles:
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers